Patents by Inventor David Mallery

David Mallery has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHARACTERIZING METHYLATED DNA, RNA, AND PROTEINS IN SUBJECTS SUSPECTED OF HAVING LUNG NEOPLASIA
    Publication number: 20220403471
    Abstract: Provided herein is technology relating to detecting neoplasia and particularly, but not exclusively, to methods, compositions, and related uses for detecting neoplasms such as lung cancer.
    Type: Application
    Filed: August 27, 2020
    Publication date: December 22, 2022
    Inventors: Scott Morris, David Mallery, Hatim T. Allawi, Graham P. Lidgard, Maria Giakoumopoulos, Michael W. Kaiser, David A. Ahlquist, William R. Taylor, Douglas W. Mahoney
  • REACTION MIXTURES FOR DETECTING NUCLEIC ACIDS ALTERED BY CANCER IN PERIPHERAL BLOOD
    Publication number: 20160333424
    Abstract: Analyzing peripheral blood RNA populations presents an effective, accurate, minimally invasive method of determining a patient's cancer status. Using circulating free RNA of the genes disclosed herein, systems and methods are disclosed which can accurately identify cancer signatures in the patient blood samples.
    Type: Application
    Filed: July 28, 2016
    Publication date: November 17, 2016
    Inventors: Scott Morris, David Mallery
  • System and method of detecting RNAS altered by cancer in peripheral blood
    Patent number: 9422592
    Abstract: Analyzing peripheral blood RNA populations presents an effective, accurate, minimally invasive method of determining a patient's cancer status. Using circulating free RNA of the genes disclosed herein, systems and methods are disclosed which can accurately identify cancer signatures in the patient blood samples.
    Type: Grant
    Filed: January 4, 2013
    Date of Patent: August 23, 2016
    Assignee: VIOMICS, INC.
    Inventors: Scott Morris, David Mallery